Sintx Technologies, Inc.

SINT ·Healthcare, Medical Devices, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2026 FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019
Revenue $1.0M $2.9M $2.6M $1.6M $606.0K $594.0K $689.0K
Cost of Revenue $557.0K $811.0K $784.0K $265.0K $449.0K $475.0K $551.0K
Gross Profit $461.0K $2.1M $1.8M $1.3M $157.0K $119.0K $138.0K
Gross Margin 45.3% 71.9% 70.2% 83.0% 25.9% 20.0% 20.0%
Operating Expenses
Research & Development $4.6M $5.2M $8.7M $6.5M $5.9M $4.8M $3.4M
SG&A Expense $6.2M $4.0M $4.2M $4.0M $3.6M $3.1M $2.9M
Operating Income $-10.7M $-14.0M $-13.4M $-11.3M $-10.6M $-8.5M $-6.6M
Operating Margin -1,053.1% -486.6% -508.5% -726.1% -1,752.5% -1,431.6% -957.0%
Interest Expense
Pretax Income $-10.4M $-11.0M $-8.3M $-12.0M $-9.3M $-7.0M $-4.8M
Income Tax Expense
Net Income $-10.4M $-11.0M $-8.3M $-12.0M $-9.3M $-7.0M $-4.8M
Net Margin -1,018.1% -381.8% -314.4% -771.2% -1,536.1% -1,183.3% -696.2%
EPS (Basic) $-6.16 $-3.72 $-110.87 $-0.98 $-0.67 $-0.02 $-0.01
EPS (Diluted) $-6.16 $-3.80 $-156.12 $-1.09 $-0.71 $-0.02 $-0.01
Shares Outstanding (Basic) 4.1M 2.8M 3.0M 14.9M 16.9M 1.38B 918.8M 958.5M
Shares Outstanding (Diluted) 4.1M 2.8M 3.0M 17.4M 17.8M 14.0M 977.0M 958.5M
Dividends Per Share
← Newer Page 1 of 2 Older →